Aspen Aerogels Inc (NYSE: ASPN) has reported a loss for its third fiscal quarter (ending September 30) of $-0.17 versus a loss $-0.19 for the same period a year ago. This result fell short of the consensus estimate of $0.01 by $-0.18. E.P.S. were $0.02 for the latest four quarters through September 30 versus $-0.85 for the same period a year ago.
Recent Price Action
Aspen Aerogels Inc (NYSE: ASPN) stock closed at $25.41 on 10/16/24 after a major increase of 13.2%. Moreover, exceptionally high trading volume at 311% of normal accompanied the advance. The stock has risen 13.4% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ASPN is expected to be Value Creation neutral.
Aspen Aerogels has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Aspen Aerogels has a very low Appreciation Score of 14 but a very high Power Rating of 98, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment